Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.33 |
| ▸ | CDC25A | P30304 | 3/20 | 0.31 |
| ▸ | CDC25B | P30305 | 3/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxirane SCHEMBL7121149 | 0.93 | CETP (0.32) | CETPLMNAOPRM1OPRD1OPRK1 | |
| SCHEMBL5545046 | 0.92 | CETP (0.39) | CETPLMNACDC25ACDC25B | |
| SCHEMBL17607217 | 0.90 | LMNA (0.39) | LMNAOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL17607274 | 0.90 | LMNA (0.39) | LMNAOPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL13814778 | 0.90 | CETP (0.37) | CETPLMNACDC25ACDC25B | |
| SCHEMBL1153604 | 0.83 | CETP (0.32) | CETP | |
| SCHEMBL596129 | 0.82 | CYP2C19 (0.33) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL596557 | 0.82 | CYP2C19 (0.33) | OPRM1OPRD1OPRK1OPRL1 | |
| SCHEMBL17607221 | 0.81 | LMNA (0.36) | CETPLMNAOPRM1OPRD1OPRK1 | |
| SCHEMBL10271778 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030009061-A1 | Process for preparing an alkylcyclohexanol alkyleneoxide adduct | INOUE YOSHIHISA (JP) | 2003-01-09 | — | — | US | disclosed |
| US-6437194-B2 | PURITY, LOW ALKYLPHENOL OR ALKYLPHENOL ALKYLENE OXIDE ADDUCT; HYDROGENATING ALKYLENE OXIDE ALKYLPHENOL ADDUCT; HYDROGENATING AN ALKYL PHENOL, REACTING ALKYLCYCLOHEXANOL; SOLVENT-FREE, WATER, AND SATURATED HYDROCARBON AS SOLVENTS | MITSUI CHEMICALS, INC. (JP) | 2002-08-20 | — | — | US | disclosed |
| US-20010051752-A1 | PROCESS FOR PREPARING AN ALKYLCYCLOHEXANOL ALKYLENE OXIDE ADDUCT | MITSUI CHEMICALS, INC. (JP) | 2001-12-13 | — | — | US | disclosed |
| EP-0945421-A1 | Alkylcyclohexanol-alkylene oxide adduct and preparation process thereof | Mitsui Chemicals, Inc. (JP) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030009061-A1 | Process for preparing an alkylcyclohexanol alkyleneoxide adduct | APEX1, ATRIP, OTUB1 | CETP 378/4885LMNA 1250/4885OPRM1 2666/4885 |
| US-20010051752-A1 | PROCESS FOR PREPARING AN ALKYLCYCLOHEXANOL ALKYLENE OXIDE ADDUCT | APEX1, ATRIP, OTUB1 | CETP 412/4885LMNA 1147/4885OPRM1 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.